Professor
University of Chicago
Chicago, Illinois
Jeffrey A Hubbell is the Eugene Bell Professor in Tissue Engineering at the Pritzker School of Molecular Engineering of the University of Chicago. With more than 400 papers and 120 issued US patents, Jeff uses biomaterials and protein engineering approaches to investigate topics in immunotherapeutics. As an engineer within translation to clinic in mind, his laboratory develops approaches to ameliorate autoimmunity and allergy, including inverse vaccination in diseases such as Type 1 diabetes, multiple sclerosis, celiac disease, food allergy and allergic asthma by promoting the body’s immune system to re-establish tolerance, and engineering of tolerogenic cytokines in the context of antigen-nonspecific approaches to the aforementioned conditions. His laboratory also develops approaches to promote the immune system to break the immune tolerance that is established by tumors, both by tumor localization of cytokines, chemokines and antibodies, and by in-situ vaccination. He was elected to the US National Academy of Engineering in 2010, the National Academy of Medicine in 2019, and the National Academy of Sciences in 2023, as well as the American Academy of Arts and Sciences in 2021. He is entrepreneurially active in translating his laboratory’s inventions to the clinic.
Disclosure information not submitted.
Keynote: Materials and Protein Engineering to Counter Inflammation and Autoimmunity
Wednesday, October 23, 2024
1:30 PM – 2:30 PM MT